MedTrace Logo

The Effect of Vitamin C on Quality of Life of Terminal Cancer Patients

NCT03224572 · Status: UNKNOWN · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2018-01-02

No results posted yet for this study

Summary

This study determines whether high dose vitamin C is effective for quality of life in terminal cancer patients.

Conditions

  • Vitamin C Deficiency

Interventions

DRUG

high-dose vitamin C 30gm

High-dose vitamin C 30 gm in 500 ml normal saline, once per week, and total 4-week treatment.

OTHER

normal saline

500ml normal saline, once per week, and total 4-week treatment

Sponsors & Collaborators

  • National Taiwan University Hospital

    lead OTHER

Principal Investigators

  • Chin-Ying Chen, MD, MHSc · National Taiwan University Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-01-31
Primary Completion
2018-12-31
Completion
2018-12-31

Countries

  • Taiwan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03224572 on ClinicalTrials.gov